Analyst upgrades typically have a positive impact on a company's stock as they indicate a positive outlook for the company's performance. In this case, the upgrade from Market Perform to Outperform suggests that the analyst believes Nektar Therapeutics will outperform the market, which could lead to an increase in the company's stock price.